The Brink's Company (BCO) Stock Forecast and Price Target (2026)

Last updated July 2026

Short answer

3 analysts covering The Brink's Company (BCO) carry an average price target of $146.33 as of October 2026, +43.2% against the $102.16 price at the time of the pull. The published targets run from $138.00 to $163.00, a spread of 17% of the average, so the disagreement is narrow. The rating split is 4 buy, 0 hold, 0 sell. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market. Walnut is not an investment adviser.

BCO analyst price targets

Price
$102.16
Average target
$146.33
Median target
$138.00
Implied vs price
+43.2%
Target range
$138.00 to $163.00
Analysts covering
3
Ratings
4 buy0 hold0 sell

BCO analyst data as of October 2026, sourced from Yahoo Finance and may be delayed. A price target is what an analyst published on a date, not a forecast Walnut endorses, and targets are typically set on a 12-month view. Verify current figures before deciding.

The average target of $146.33 sits well above the $102.16 price, +43.2%. The median is $138.00, and where the two differ the median is the steadier read, because one unusually high or low target cannot drag it.

What the BCO target range actually tells you

The published targets span $138.00 to $163.00. That gap is 17% of the average target, which counts as narrow disagreement. A spread that tight means the analysts broadly agree on the model, so the consensus is a reasonably stable read rather than an average of wildly different views.

The useful move is to read the high target as one bull scenario and the low target as one bear scenario, then ask which set of assumptions you find more plausible. Both cases are worked through on the BCO is it a buy page.

How analysts rate BCO

Of the analysts with a published rating, 4 say buy, 0 say hold, and 0 say sell, so 100% carry a buy. That mix has been broadly steady over the last three months.

Read the distribution rather than the label. Sell ratings are rare across the entire market for structural reasons, so a stock with no sell ratings is unremarkable, while even a handful of them is worth understanding.

Why a BCO price target is not a prediction

  • It is a 12-month model output. An analyst picks assumptions for revenue, margin, and a multiple, and the target falls out of the arithmetic. Change one assumption and the target moves a lot.
  • The distribution is skewed. Sell-side coverage carries far more buy ratings than sell ratings across the whole market, so the average is not a balanced vote.
  • Targets follow price as often as they lead it. Revisions frequently arrive after a move, not before, which is why a rising target is weak evidence on its own.
  • Nobody is scored on it. There is no cost to a target that never gets close, so treat accuracy as unverified unless you check the firm's record yourself.

Is there a 2030 forecast for BCO?

Not a published one. Analyst price targets run to about twelve months, occasionally two years, and the firms covering BCO do not put out a 2030 number. Anything presenting one is extrapolating a growth rate rather than reporting research, and a figure produced that way tells you about the assumption chosen, not about the company.

On the figures we hold as of October 2026, BCO trades at about 23.6 times trailing earnings and 9.9 times forward earnings. A forward multiple below the trailing one means the market expects earnings to grow, and the size of that gap is roughly how much growth is already in the price.

That is the more useful frame for a ten-year question. A share price is the market’s estimate of future cash flows discounted to today, so the multiple is already a statement about growth. The long-horizon question is whether The Brink's Company can deliver what is priced in, and what would have to change for that to break. Both are answerable from the drivers and risks below. A number for 2030 is not.

What could move BCO from here

In short: the drivers cited most often are ATM Managed Services and Digital Retail Solutions, The NCR Atleos acquisition, Margin expansion and cash conversion. The risk cited most often against it is leverage is the dominant risk: Brink's already carries ~$4.56 billion of total debt against ~$1.66 billion of cash, and financing a $6.6 billion acquisition on a ~$4.6 billion equity base would push the balance sheet considerably further, with an Altman Z-Score of ~1.67 flagging balance-sheet strain even before the deal.

Both sides are worked through properly, with the high and low targets used as the bull and bear anchors, on the BCO is it a buy page. This page deliberately stops at the numbers.

Investing in The Brink's Company with AI

Connect the broker you already use and ask Walnut's AI how BCO fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.

FAQ

What is the price target for The Brink's Company (BCO)?

+

The average analyst price target for BCO is $146.33 as of October 2026, across 3 analysts. That is +43.2% against the $102.16 price at the time of the data pull, so the consensus sits well above where the stock trades. The median target, which is less distorted by one extreme view, is $138.00. Targets move constantly; verify the current figure before relying on it.

How high could BCO go?

+

The highest published target is $163.00, which is +59.6% against the $102.16 price. That is one analyst's most optimistic case, not a ceiling and not a forecast. The lowest is $138.00. The gap between them is the honest answer to this question: analysts who all follow The Brink's Company closely disagree by 17% of the average target, so treat any single number as one scenario.

How many analysts cover BCO?

+

3 analysts publish estimates on BCO as of October 2026. Of those with a published rating, 4 say buy, 0 hold, and 0 sell, so 100% carry a buy rating. More coverage usually means the consensus is better informed, though it also means the obvious points are already in the price.

Are analyst price targets for BCO accurate?

+

Treat them as informed opinion, not measurement. Two things are worth knowing. Sell-side ratings skew positive across the market, and BCO is no exception at 100% buy ratings, so the distribution is not a balanced vote. And targets tend to follow the share price at least as often as they lead it, getting raised after a stock has already run. They are most useful as a read on what the informed consensus expects, and least useful as a prediction of where the price lands.

What is the BCO stock price prediction for 2030?

+

There is no published one. Analyst targets run to about twelve months and no firm covering BCO publishes a 2030 figure, so any site showing one has extrapolated a growth rate rather than reported research. The answerable version of the question is what the current price already assumes about The Brink's Company's earnings, which the forward multiple on this page sets out, and what would have to change for that to break.

Will BCO go up in 2026?

+

Nobody knows, including the analysts publishing targets. What the numbers on this page tell you is where informed opinion currently sits and how much it disagrees with itself, which is genuinely useful and completely different from a prediction. The risk most often cited against The Brink's Company: Leverage is the dominant risk: Brink's already carries ~$4.56 billion of total debt against ~$1.66 billion of cash, and financing a $6.6 billion acquisition on a ~$4.6 billion equity base would push the balance sheet considerably further, with an Altman Z-Score of ~1.67 flagging balance-sheet strain even before the deal. Walnut is not an investment adviser.

Walnut is informational, not investment advice, and does not publish price targets of its own. The analyst figures on this page come from a October 2026 data pull of published third-party research, are approximate, and change constantly. Verify current figures with your broker before acting on them.

Forecasts for similar stocks